Aberrant NF-κB2/p52 expression in Hodgkin/Reed–Sternberg cells and CD30-transformed rat fibroblasts (original) (raw)
References
Annunziata CM, Safiran YJ, Irving SG, Kasid UN and Cossman J . (2000). Blood, 96, 2841–2848.
Atkinson PGP, Coope HJ, Rowe M and Ley SC . (2003). J. Biol. Chem., 278, 51134–51142.
Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C and Dörken B . (1997). J. Clin. Invest., 100, 2961–2969.
Barth TFE, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G, Parwaresch RM, Lichter P, Siebert R and Möller P . (2003). Blood, 101, 3681–3686.
Ben-Neriah Y and Schmitz ML . (2004). EMBO Rep, 5, 668–673.
Cabannes E, Khan G, Aillet F, Jarrett RF and Hay RT . (1999). Oncogene, 18, 3063–3070.
Carbone A, Gloghini A, Gattei V, Aldinucci D, Degan M, Paoli P, De Zagonel V and Pinto A . (1995). Blood, 85, 780–789.
Chinanonwait N, Miura H, Yamamoto N and Yamaoka S . (2002). FEBS Lett., 531 (3), 553–560.
Claudio E, Brown K, Park S, Wang H and Siebenlist U . (2002). Nat. Immunol., 3, 958–965.
Cogswell PC, Guttridge DC, Funkhouser WK and Baldwin AS . (2000). Oncogene, 19, 1123–1131.
Coope HJ, Atkinson PGP, Huhse B, Belich M, Janzen J, Holman MJ, Klaus GGB, Johnston LH and Ley SC . (2002). EMBO J., 21, 5375–5385.
Dejardin E, Deregowski V, Chapelier M, Jacobs N, Gielen J, Merville MP and Bours V . (1999). Oncogene, 18, 2567–2577.
Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C, Li ZW, Karin M, Ware CF and Green DR . (2002). Immunity, 17, 525–535.
Derudder E, Dejardin E, Pritchard LL, Green DR, Körner M and Baud V . (2003). J. Biol. Chem., 278, 23278–23284.
Eliopoulos AG, Caamano JH, Flavell J, Reynolds GM, Murray, PG, Poyet JL and Young LS . (2003). Oncogene, 22, 7557–7569.
Emmerich F, Theurich S, Hummel M, Haeffker A, Vry MS, Döhner K, Bommert K, Stein H and Dörken B . (2003). J. Pathol., 201, 413–420.
Fiumara P, Snell V, Li Y, Mukhopadhyay A, Younes M, Gillenwater AM, Cabanillas F, Aggarwal BB and Younes A . (2001). Blood, 98, 2784–2790.
Hanada K, Tsunoda R and Hamada H . (1996). J. Leukoc. Biol., 60, 181–190.
Hinz M, Lemke P, Anagnostopoulos I, Hacker C, Krappmann D, Mathas S, Dörken B, Zenke M, Stein H and Scheidereit C . (2002). J. Exp. Med., 196, 605–617.
Hironaka N, Mochida K, Mori N, Maeda M, Yamamoto N and Yamaoka S . (2004). Neoplasia, 6, 266–278.
Horie R, Higashihara M and Watanabe T . (2003). Int. J. Hematol., 77, 37–47.
Horie R, Watanabe M, Ishida T, Koiwa T, Aizawa S, Itoh K, Higashihara M, Kadin ME and Watanabe T . (2004). Cancer Cell, 5, 353–364.
Horie R, Watanabe T, Morishita Y, Ito K, Ishida T, Kanegae Y, Saito I, Higashihara M, Mori S, Kadin ME and Watanabe T . (2002). Oncogene, 21, 2493–2503.
Hsu H, Shu HB, Pan MG and Goeddel DV . (1996). Cell, 84, 299–308.
Hübinger G, Schneider C, Stöhr D, Ruff H, Kirchner D, Schwänen C, Schmid M, Bergmann L and Müller E . (2004). Exp. Hematol., 32, 382–389.
Kawakami Y, Miura T, Bissonnette R, Hata D, Khan WN, Kitamura T, Maeda-Yamamoto M, Hartman SE, Yao L, Alt FW and Kawakami T . (1997). Proc. Natl. Acad. Sci. USA, 94, 3938–3942.
Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin JP, Starovasnik MA and Dixit VM . (2002). Immunity, 17, 515–524.
Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dörken B and Scheidereit C . (1999). Oncogene, 18, 943–953.
Küppers R, Klein U, Schwering I, Distler V, Bräninger A, Cattoretti G, Tu Y, Stolovitzky GA, Califano A, Hansmann M-L and Dalla-Favera R . (2003). J. Clin. Invest., 111, 529–537.
Liao G, Zhang M, Harhaj EW and Sun SC . (2004). J. Biol. Chem., 279, 26243–26250.
Li Q and Verma ML . (2002). Nat. Rev. Immunol., 2, 725–734.
Makris C, Roberts JL and Karin M . (2002). Mol. Cell. Biol., 22, 6573–6581.
Martín-Subero JI, Gesk S, Harder L, Sonoki T, Tucker PW, Schlegelberger B, Grote W, Novo FJ, Calasanz MJ, Hansmann ML, Dyer MJS and Siebert R . (2002). Blood, 99, 1474–1477.
Mathas S, Lietz A, Janz M, Hinz M, Jundt F, Scheidereit C, Bommert K and Dörken B . (2003). Blood, 102, 1028–1034.
Mori N, Fujii M, Iwai K, Ikeda S, Yamasaki Y, Hata T, Yamada Y, Tanaka Y, Tomonaga M and Yamamoto N . (2000). Blood, 95, 3915–3921.
Morita S, Kojima T and Kitamura T . (2000). Gene Ther., 7, 1063–1066.
Müller JR and Siebenlist U . (2003). J. Biol. Chem., 278, 12006–12012.
Munoz E, Courtois G, Veschambre P, Jalinot P and Israël A . (1994). J. Virol., 68, 8035–8044.
Novack DV, Yin L, Hagen-Stapleton A, Schreiber RD, Goeddel DV, Ross FP and Teitelbaum SL . (2003). J. Exp. Med., 198, 771–781.
Opat S and Gaston JS . (2000). Autoimmunity, 33, 45–60.
Saito N, Courtois G, Chiba A, Yamamoto N, Nitta T, Hironaka N, Rowe M, Yamamoto N and Yamaoka S . (2003). J. Biol. Chem., 278, 46565–46575.
Saitoh T, Nakayama M, Nakano H, Yagita H, Yamamoto N and Yamaoka S . (2003). J. Biol. Chem., 278, 36005–36012.
Schneider C and Hübinger G . (2002). Leuk. Lymphoma, 43, 1355–1366.
Skinnider BF and Mak TW . (2002). Blood, 99, 4283–4297.
Solan NJ, Miyoshi H, Carmona EM, Bren GD and Paya CV . (2002). J. Biol. Chem., 277, 1405–1418.
Stein H, Foss HD, Dürkop H, Marafioti T, Delsol G, Pulford K, Pileri S and Falini B . (2000). Blood, 96, 3681–3695.
Sugamura K, Fujii M, Kannagi M, Sakitani M, Takeuchi M and Hinuma Y . (1984). Int. J. Cancer., 34, 221–228.
Takahashi Y, Tanaka Y, Yamashita A, Koyanagi Y, Nakamura M and Yamamoto N . (2001). J. Virol., 75, 6748–6757.
Thomas RK, Re D, Wolf J and Diehl V . (2004). Lancet Oncol., 5, 11–18.
Whiteside ST, Ernst MK, LeBail O, Laurent-Winter C, Rice N and Israël A . (1995). Mol. Cell. Biol., 15, 5339–5345.
Xiao G, Cvijic ME, Fong A, Harhaj EW, Uhlik MT, Waterfield M and Sun SC . (2001). EMBO J., 20, 6805–6815.
Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ and Israël A . (1998). Cell, 93, 1231–1240.
Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, Yamada T and Hatanaka M . (1996). EMBO J., 15, 873–887.
Zheng B, Fiumara P, Li YV, Georgakis G, Snell V, Younes M, Vauthey JN, Carbone A and Younes A . (2003). Blood, 102, 1019–1027.